Sponsor
The First Affiliated Hospital of Soochow University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name The First Affiliated Hospital of Soochow University appears in 36 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
36 shownTrastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast CancerNCT07647263 · lead sponsor · 2026-03-24
RECRUITINGA Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With AsthmaNCT07015749 · lead sponsor · 2025-06-20
RECRUITINGThe Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single CenterNCT07552285 · lead sponsor · 2025-05-01
RECRUITINGGeneration of Reactive T Cells Based on Tumor Whole Cell Antigen NanovaccinesNCT07239544 · lead sponsor · 2025-07-10
ACTIVE_NOT_RECRUITINGA Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer PatientsNCT05210946 · lead sponsor · 2021-12-06
UNKNOWNTo Explore the Related Factors of Cough After Thoracoscopic PneumonectomyNCT04204148 · lead sponsor · 2019-12-01
UNKNOWNAnlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung CancerNCT03766490 · lead sponsor · 2019-03-30
UNKNOWNThe Affection of Two Chest Management for Enhanced Recovery Program After Video-assisted Thoracoscopic Lobectomy.NCT03598296 · lead sponsor · 2018-07-28
COMPLETEDRisk Factors for Predictors of In-hospital Death in Acute Fulminant MyocarditisNCT03219996 · lead sponsor · 2016-01-01
COMPLETEDDiagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLDNCT07632677 · collaborator · 2026-05-15
RECRUITINGiWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight LossNCT07237750 · collaborator · 2026-03-01
RECRUITINGGVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle GlaucomaNCT06921317 · collaborator · 2025-11-19
RECRUITINGRadiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPCNCT06992232 · collaborator · 2024-08-01
RECRUITINGCSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization TherapyNCT06241651 · collaborator · 2024-01-01
RECRUITINGEfficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes RemissionNCT05015283 · collaborator · 2022-02-01
RECRUITINGApplication of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate CancerNCT07238959 · collaborator · 2025-12-01
NOT_YET_RECRUITINGTranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral HemorrhageNCT06760078 · collaborator · 2024-12-31
NOT_YET_RECRUITINGThe Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis AnalysisNCT06589154 · collaborator · 2024-10-10
COMPLETEDApplication of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate CancerNCT06509919 · collaborator · 2024-07-09
SUSPENDEDTGRX-326 Pharmacokinetic Mass BalanceNCT06438367 · collaborator · 2024-06-26
COMPLETEDEfficacy of Henagliflozin for Weight Loss in Obesity Without DiabetesNCT06216340 · collaborator · 2024-02-15
UNKNOWNCirculating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)NCT05947188 · collaborator · 2023-11-01
UNKNOWNA Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNCT05824923 · collaborator · 2023-08-14
ACTIVE_NOT_RECRUITINGTreatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell TherapyNCT05638776 · collaborator · 2022-12-06
COMPLETEDArtificial Intelligence-Based Computer-Aided Diagnosis of Prostate CancerNCT05513638 · collaborator · 2022-08-22
UNKNOWNIndependent Predictors Analysis and Model Construction of Cavitary Central Lung CancerNCT05278754 · collaborator · 2022-03-12
UNKNOWNA Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate CancerNCT05376722 · collaborator · 2022-02-22
UNKNOWNEfficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate CancerNCT05249712 · collaborator · 2022-01-01
UNKNOWNMulti-center Study of Deep Learning AI in Breast MassNCT05443672 · collaborator · 2021-08-12
UNKNOWNThe Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate CancerNCT04992026 · collaborator · 2021-01-01
COMPLETEDPD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate CancerNCT05732948 · collaborator · 2018-08-02
UNKNOWNAutologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PFNCT03153800 · collaborator · 2017-04-05
UNKNOWNEfficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminNCT02280486 · collaborator · 2015-01-01
COMPLETEDGefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR MutationNCT01405079 · collaborator · 2011-09-19
UNKNOWNIntercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung CancerNCT01404260 · collaborator · 2011-06-01
COMPLETEDErlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR MutationsNCT01410214 · collaborator · 2011-05-01
UNKNOWNSponsor roles
collaborator27
lead sponsor9
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.